Avid Bioservices, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CDMO research report →
About the company
Avid Bioservices, Inc. operates as a Contract Development and Manufacturing Organization (CDMO), specializing in the development and CGMP-compliant production of biopharmaceutical drug substances. Their core expertise lies in compounds derived from mammalian cell culture, providing both clinical and commercial scale manufacturing solutions.
- CEO
- Nicholas Stewart Green MBA
- IPO
- 1994
- Employees
- 371
- HQ
- Tustin, CA, US
Price Chart
- Market Cap
- $798.90M
- P/E
- -5.60
- P/S
- 5.71
- P/B
- 12.96
- EV/EBITDA
- -84.37
- Div Yield
- 0.00%
- Gross Margin
- 5.23%
- Op Margin
- -13.35%
- Net Margin
- -100.60%
- ROE
- -112.44%
- ROIC
- -6.95%
- Revenue
- $139.91M · -6.27%
- Net Income
- $-140,753,000 · -25234.46%
- EPS
- $-2.23 · -24877.78%
- Op Income
- $-18,678,000
- FCF YoY
- 76.96%
- 52W High
- $12.51
- 52W Low
- $5.90
- 50D MA
- $12.36
- 200D MA
- $10.25
- Beta
- 1.41
- Avg Volume
- 1.58M
Get TickerSpark's AI analysis on CDMO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Feb 5, 25 | Ziebell Mark R | sell | 14,286 |
| Feb 5, 25 | Ziebell Mark R | sell | 21,429 |
| Feb 5, 25 | Ziebell Mark R | sell | 1,733 |
| Feb 5, 25 | Ziebell Mark R | sell | 98,120 |
| Feb 5, 25 | Ziebell Mark R | sell | 17,679 |
| Feb 5, 25 | Ziebell Mark R | sell | 51,413 |
| Feb 5, 25 | Ziebell Mark R | sell | 55,310 |
| Feb 5, 25 | Ziebell Mark R | sell | 108,579 |
| Feb 5, 25 | Ziebell Mark R | sell | 66,799 |
| Feb 5, 25 | Thoma Jeanne | sell | 45,611 |
Our CDMO coverage
Recent articles, reports, and earnings notes.
No research on CDMO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CDMO report →Similar companies
Peers in the same neighborhood.